# OnCo record paper-chapuis-il21-ctl-ipilimumab-jco-2016 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-chapuis-il21-ctl-ipilimumab-jco-2016/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-chapuis-il21-ctl-ipilimumab-jco-2016" ;
  schema:name "T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression"@en ;
  schema:description "Ten people with stage IV melanoma were given their own MART-1-targeting T cells followed by the immunotherapy drug ipilimumab. Two had lasting complete remissions and the infused cells were still found in the blood months later."@en ;
  schema:url <https://onco.cc/key-papers/paper-chapuis-il21-ctl-ipilimumab-jco-2016/> ;
  schema:dateModified "2026-11-05"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2015.65.5142>, <https://pubmed.ncbi.nlm.nih.gov/27269940/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.2015.65.5142> ;
  schema:datePublished "2016"^^xsd:gYear ;
  schema:author "Chapuis AG, Roberts IM, Thompson JA, Margolin KA, Bhatia S, Lee SM, Sloan HL, Lai IP, Farrar EA, Wagener F, Shibuya KC, Cao J, Wolchok JD, Greenberg PD, Yee C." ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:drugs <https://onco.cc/drugs/ipilimumab/> ;
  onco:institutions <https://onco.cc/institutions/fred-hutch/> ;
  onco:terms <https://onco.cc/terms/endogenous-t-cell-therapy/> ;
  onco:people <https://onco.cc/people/cassian-yee/> ;
  onco:journals <https://onco.cc/journals/jco/> .